ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.766,00
-0,58%
S&P 500
5.300,50
1,03%
US Dollar vs BRL
5,1358
0,13%
Bitcoin
65.322,96
6,14%
Brent Oil
82,55
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Windtree Therapeutics Com (DSCO)

  7. Windtree Therapeutics Com (DSCO) Notícias

DSCO

Discovery labs (DSCO)

Windtree Therapeutics Com
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:DSCO
DataHoraFonteTítuloCódigoCompanhia
18/04/201617:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DSCOWindtree Therapeutics Com
18/04/201609:30PR Newswire (US)Discovery Labs Changes Name to Windtree Therapeutics, Inc. (NASDAQ: WINT)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201618:30Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201618:30Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:DSCOWindtree Therapeutics Com
29/03/201607:06Edgar (US Regulatory)Annual Report (10-k)NASDAQ:DSCOWindtree Therapeutics Com
24/03/201608:00PR Newswire (US)Discovery Labs Reports Fourth Quarter 2015 Financial Results and Provides Business UpdatesNASDAQ:DSCOWindtree Therapeutics Com
16/03/201618:15PR Newswire (US)Discovery Labs to Report Fourth Quarter 2015 Financial Results and Host Conference Call on Thursday, March 24, 2016NASDAQ:DSCOWindtree Therapeutics Com
16/02/201614:17Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:DSCOWindtree Therapeutics Com
16/02/201612:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:DSCOWindtree Therapeutics Com
03/02/201621:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DSCOWindtree Therapeutics Com
03/02/201619:06PR Newswire (US)Discovery Labs Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:DSCOWindtree Therapeutics Com
02/02/201619:40Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DSCOWindtree Therapeutics Com
01/02/201619:01PR Newswire (US)Discovery Labs Announces Appointment of New Chief Executive Officer and Provides an Update on AEROSURF® Phase 2 ProgramNASDAQ:DSCOWindtree Therapeutics Com
21/01/201619:10PR Newswire (US)Discovery Labs Announces Reverse Stock SplitNASDAQ:DSCOWindtree Therapeutics Com
13/01/201620:18Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:DSCOWindtree Therapeutics Com
13/01/201619:30Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DSCOWindtree Therapeutics Com
29/12/201519:05PR Newswire (US)Discovery Labs Announces Initiation of AEROSURF® Phase 2b Clinical TrialNASDAQ:DSCOWindtree Therapeutics Com
14/12/201520:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DSCOWindtree Therapeutics Com
10/12/201510:30PR Newswire (US)Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestational Age Presented at the 2015 Hot...NASDAQ:DSCOWindtree Therapeutics Com
02/12/201520:20Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:DSCOWindtree Therapeutics Com
12/11/201510:00PR Newswire (US)Discovery Labs Announces Top Line Results of AEROSURF® Phase 2a Clinical Program in Premature Infants 29 to 34 Weeks Gestati...NASDAQ:DSCOWindtree Therapeutics Com
06/11/201511:30PR Newswire (US)Discovery Labs to Announce Results from AEROSURF® Phase 2a Expansion Clinical TrialNASDAQ:DSCOWindtree Therapeutics Com
05/11/201519:15PR Newswire (US)Discovery Labs Provides Business Update and Reports Third Quarter 2015 Financial ResultsNASDAQ:DSCOWindtree Therapeutics Com
21/10/201509:30PR Newswire (US)Discovery Labs Announces Completion of Enrollment in AEROSURF® Phase 2a Dose Expansion TrialNASDAQ:DSCOWindtree Therapeutics Com
10/08/201518:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DSCOWindtree Therapeutics Com
10/08/201517:45PR Newswire (US)Discovery Labs Provides Business Update and Reports Second Quarter 2015 Financial ResultsNASDAQ:DSCOWindtree Therapeutics Com
03/08/201517:15PR Newswire (US)Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other ...NASDAQ:DSCOWindtree Therapeutics Com
30/07/201508:30PR Newswire (US)Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfacta...NASDAQ:DSCOWindtree Therapeutics Com
22/07/201517:15PR Newswire (US)Discovery Labs Announces Completion of $40.25 Million Public OfferingNASDAQ:DSCOWindtree Therapeutics Com
21/07/201514:39Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:DSCOWindtree Therapeutics Com
 Apresentando as notícias mais relevantes sobre:NASDAQ:DSCO

Seu Histórico Recente

NYSE
LZ
Lubrizol
CSE
RWI
River Wild Exploration Inc.
USOTC
SSRT
Streetex (PK)
TSX
MR.DB.B
Melcor Real Estate Inves...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados